AMG 794
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 794, covering 2025-10-08 to 2025-10-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications [Phase 1]